AFC-HD AMS Life Science Co., Ltd. (TYO:2927)
Japan · Delayed Price · Currency is JPY 864.00
-2.00 (-0.23%)
Sep 4, 2026, 3:30 PM JST
AFC-HD AMS Life Science Ratios and Metrics
Market cap in millions JPY. Fiscal year is September - August.
Millions JPY. Fiscal year is Sep - Aug.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
| 12,579 | 12,176 | 11,714 | 11,121 | 10,805 | 16,207 | |
Market Cap Growth | 4.77% | 3.94% | 5.33% | 2.93% | -33.33% | 70.72% |
Enterprise Value | 26,868 | 25,268 | 22,965 | 19,690 | 18,335 | 20,487 |
Last Close Price | 864.00 | 828.05 | 766.02 | 707.65 | 661.55 | 950.02 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
PE Ratio | 10.31 | 8.41 | 9.36 | 10.09 | 14.70 | 10.84 |
PS Ratio | 0.38 | 0.37 | 0.39 | 0.44 | 0.47 | 0.73 |
PB Ratio | 0.77 | 0.80 | 0.84 | 0.85 | 0.87 | 1.28 |
P/TBV Ratio | 0.88 | 0.93 | 1.03 | 0.95 | 0.98 | 1.58 |
P/FCF Ratio | - | - | - | - | 20.20 | 7.75 |
P/OCF Ratio | 4.13 | 6.82 | 7.61 | 12.86 | 7.24 | 6.28 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
EV/Sales Ratio | 0.81 | 0.77 | 0.76 | 0.77 | 0.80 | 0.92 |
EV/EBITDA Ratio | 6.74 | 6.64 | 7.66 | 7.52 | 9.09 | 7.08 |
EV/EBIT Ratio | 11.39 | 10.48 | 11.99 | 12.03 | 18.12 | 9.12 |
EV/FCF Ratio | - | - | - | - | 34.27 | 9.80 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Debt / Equity Ratio | 1.44 | 1.57 | 1.64 | 1.49 | 1.38 | 1.16 |
Debt / EBITDA Ratio | 5.94 | 6.28 | 7.63 | 7.46 | 8.49 | 5.07 |
Debt / FCF Ratio | - | - | - | - | 32.03 | 7.02 |
Net Debt / Equity Ratio | 0.85 | 0.83 | 0.77 | 0.64 | 0.54 | 0.43 |
Net Debt / EBITDA Ratio | 3.51 | 3.31 | 3.57 | 3.19 | 3.35 | 1.89 |
Net Debt / FCF Ratio | - | -7.20 | -5.74 | -7.78 | 12.63 | 2.61 |
Asset Turnover | 0.67 | 0.68 | 0.69 | 0.65 | 0.63 | 0.82 |
Inventory Turnover | 2.84 | 3.29 | 3.81 | 4.02 | 3.81 | 4.53 |
Quick Ratio | 0.49 | 0.55 | 0.85 | 0.94 | 0.98 | 0.97 |
Current Ratio | 0.82 | 0.86 | 1.25 | 1.34 | 1.30 | 1.34 |
Return on Equity (ROE) | 7.47% | 10.07% | 9.19% | 8.64% | 5.87% | 12.93% |
Return on Assets (ROA) | 2.99% | 3.15% | 2.72% | 2.61% | 1.73% | 5.17% |
Return on Invested Capital (ROIC) | 5.06% | 6.13% | 5.41% | 5.76% | 3.24% | 11.20% |
Return on Capital Employed (ROCE) | 10.20% | 10.60% | 6.50% | 6.20% | 4.20% | 9.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Earnings Yield | 9.56% | 11.89% | 10.69% | 9.91% | 6.80% | 9.22% |
FCF Yield | -3.17% | -14.39% | -15.93% | -9.66% | 4.95% | 12.90% |
Dividend Yield | 4.16% | 4.11% | 3.92% | 3.89% | 4.54% | 2.90% |
Payout Ratio | - | 29.97% | 33.39% | 34.94% | 57.28% | 20.87% |
Buyback Yield / Dilution | -1.95% | -0.12% | 0.01% | 0.47% | -0.36% | -0.04% |
Total Shareholder Return | 2.21% | 3.99% | 3.92% | 4.36% | 4.18% | 2.85% |